Estados Unidos · Revistas de economía · Axios Markets

Exclusive: OpenAI acquires biotech startup as AI race moves into drug development

Publicado por Axios Markets · Estados Unidos hace 10 h

OpenAI has acquired Orchestra Bio, a startup building AI agents to help pharmaceutical companies manage drug development, the ChatGPT maker shared exclusively with Axios. Why it…

Leer el artículo completo en Axios Markets Inicie sesión para guardar

MarketNews muestra el titular y el resumen publicados por el medio. El artículo completo se lee en el sitio del editor. (www.axios.com)

Exclusive: OpenAI acquires biotech startup as AI race moves into drug development

También te puede interesar

The 20 most visited museums on Earth, ranked by attendance

Goldman sees a housing freeze through 2027. It would lock in an economic divide between millennials

LinkedIn’s CEO Stepped Down Rather Than Relocate. His Choice Reveals What Career Fit Really Means

AI coding has hit an 'intelligence saturation' point, Cognition cofounder says

Retirement used to be a big-company perk

United Airlines CEO Calls for New Taxes on Wealth and Inheritances: What That Would Mean for Your Money

Exclusive: OpenAI acquires biotech startup as AI race moves into drug development

Compartir

También te puede interesar

The 20 most visited museums on Earth, ranked by attendance

Goldman sees a housing freeze through 2027. It would lock in an economic divide between millennials

LinkedIn’s CEO Stepped Down Rather Than Relocate. His Choice Reveals What Career Fit Really Means

AI coding has hit an 'intelligence saturation' point, Cognition cofounder says

Retirement used to be a big-company perk

United Airlines CEO Calls for New Taxes on Wealth and Inheritances: What That Would Mean for Your Money